Haw Par Stock Shares Outstanding

HAWPF Stock  USD 8.37  0.00  0.00%   
Haw Par fundamentals help investors to digest information that contributes to Haw ParLimited's financial success or failures. It also enables traders to predict the movement of Haw Pink Sheet. The fundamental analysis module provides a way to measure Haw ParLimited's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Haw ParLimited pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Haw Par Company Shares Outstanding Analysis

Haw ParLimited's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Haw ParLimited Shares Outstanding

    
  221.37 M  
Most of Haw ParLimited's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Haw Par is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Based on the latest financial disclosure, Haw Par has 221.37 M of shares currently outstending. This is 22.62% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The shares outstanding for all United States stocks is 61.29% higher than that of the company.

Haw Shares Outstanding Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Haw ParLimited's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Haw ParLimited could also be used in its relative valuation, which is a method of valuing Haw ParLimited by comparing valuation metrics of similar companies.
221.4M5.7B2.5B2.4B100%
Haw Par is currently under evaluation in shares outstanding category among its peers.

Haw Fundamentals

About Haw ParLimited Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Haw Par's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Haw ParLimited using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Haw Par based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Haw Pink Sheet

Haw ParLimited financial ratios help investors to determine whether Haw Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Haw with respect to the benefits of owning Haw ParLimited security.


 

Trending Assets

AMGN
Amgen Inc
316.04  0.00  0.00 
ABBV
AbbVie Inc
210.01  0.00  0.00 
GSK
GlaxoSmithKline PLC ADR
39.24  -0.17  -0.43 
GILD
Gilead Sciences
107.08  0.00  0.00 
OGN
Organon
15.39  -0.21  -1.35 
LLY
Eli Lilly
837.57  0.00  0.00 
JNJ
Johnson Johnson
163.63  0.61  0.37 
NVS
Novartis AG ADR
112.13  -1.08  -0.95 
MRK
Merck Company
93.11  -1.62  -1.71 
BMY
Bristol Myers Squibb
61.07  0.65  1.08 
PFE
Pfizer Inc
26.28  0.09  0.34 
News Freq…Investor S…